Discounted Cash Flow Rating

Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Strong Sell

Analyst Rating

Neutral

Simple Moving Average

Strong Sell

Exponential Moving Average

Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Buy

Wall Street Data Solutions Rating

Neutral

B

Avadel Pharmaceuticals plc American Depositary Shares (AVDL)

Pharmaceutical Preparations

https://www.avadel.com

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company markets products in both the primary care and sterile injectables markets. Its products portfolio includes Bloxiverz, Vazculep (phenylephrine hydrochloride injection), Akovaz (ephedrine sulfate injection), Karbinal ER (carbinoxamine maleate extended-release oral suspension), AcipHex Sprinkle (rabeprazole sodium), Cefaclor for Oral Suspension, 125 mg/5 mL, 250 mg/5 mL and 375 mg/5 mL, and Flexichamber. Majority of the revenue is derived from the United States.

BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK, BALLYCOOLIN
DUBLIN, L2

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

06/07/1996

Market Cap

1,537,439,885

Shares Outstanding

89,810,000

Weighted SO

89,805,653

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

NBIX --.--%

DCPH --.--%

IRWD --.--%

ALKS --.--%

ITCI --.--%

DVAX --.--%

DERM --.--%

EVOK --.--%

JUPW --.--%

Beta

1.6320

Last Div

0.0000

Range

9.5-19.09

Chg

0.6200

Avg Vol

1232709

Mkt Cap

1537439885

Exch

NASDAQ

Country

IE

Phone

353 1 901 5201

DCF Diff

15.7923

DCF

-0.1223

Div Yield

0.0000

P/S

16.1582

EV Multiple

-15.9030

P/FV

21.8463

Div Yield %

0.0000

P/E

-14.4556

PEG

-1.1415

Payout

0.0000

Current Ratio

2.8194

Quick Ratio

2.5209

Cash Ratio

0.6466

DSO

131.5932

DIO

949.0713

Op Cycle

1080.6645

DPO

698.2051

CCC

382.4594

Gross Margin

0.9462

Op Margin

-1.0382

Pretax Margin

-1.1209

Net Margin

-1.1164

Eff Tax Rate

0.0040

ROA

-0.6743

ROE

-1.2260

ROCE

-0.8749

NI/EBT

0.9960

EBT/EBIT

1.0796

EBIT/Rev

-1.0382

Debt Ratio

0.2308

D/E

0.5173

LT Debt/Cap

0.3355

Total Debt/Cap

0.3409

Int Coverage

-23.4758

CF/Debt

-3.1341

Equity Multi

2.2411

Rec Turnover

2.7737

Pay Turnover

0.5228

Inv Turnover

0.3846

FA Turnover

36.0686

Asset Turnover

0.6040

OCF/Share

-1.1852

FCF/Share

-1.1852

Cash/Share

0.7424

OCF/Sales

-1.1976

FCF/OCF

1.0000

CF Coverage

-3.1341

ST Coverage

-131.5861

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

21.8463

P/B

21.8463

P/S

16.1582

P/E

-14.4556

P/FCF

-13.4918

P/OCF

-13.4751

P/CF

-13.4751

PEG

-1.1415

P/S

16.1582

EV Multiple

-15.9030

P/FV

21.8463

DPS

0.0000

Latest Headlines (EST)

Benzinga Dec 20, 12:00 Needham Maintains Buy Rating for Avadel Pharmaceuticals: Here's What You Need To Know

Revenue Product Segmentation